Breast cancer AI firm Volpara sees strong cash receipts

Breast cancer AI firm Volpara sees strong cash receipts
Rebecca Howard
ASX-listed Volpara Health Technologies collected its highest quarterly cash receipts since listing in 2016. Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, said it received nearly $5.0 million in the first quarter to June 20, up 112 percent on the year.  It was the fourth straight quarter with cash receipts over $4.5 million. “Q1 saw the emergence of covid-19, but we’re very heartened by the strong cash receipts, negligible churn, and the fact that we got a significant number of n...

More Services

Two MC partners quit for specialist firm
Services

Two MC partners quit for specialist firm

Cuncannon now has a broader commercial offering. 

Staff reporters 06 Oct 2025
DB Breweries appoints new MD
Retail

DB Breweries appoints new MD

Peter Hart returns to NZ.

Victoria Young 01 Oct 2025
2degrees earnings show cash momentum
Services

2degrees earnings show cash momentum

Non-cash costs mask strong operating earnings and cashflow.

Pattrick Smellie 24 Sep 2025
Airwork on the block to repay $145m of bank debt
Law & Regulation

Airwork on the block to repay $145m of bank debt

Airwork has an outstanding intercompany loan of $35.83m, owes trade creditors $219,000.

Denise McNabb 11 Sep 2025